Morning-after pill ruling causes controversy in the United States



U.S. Health Secretary Says 'No' to Morning-After Pill for Younger Teens

FDA was ready to make Plan B available to girls under 16 without a prescription.

By Robert Preidt, HealthDay News

Don't Miss This

Sign Up for OurSexual HealthNewsletter

Thanks for signing up!You might also like these other newsletters:

WEDNESDAY, Dec. 7, 2011 (HealthDay News) —The emergency contraceptive called Plan B will not be made available without a prescription to young women under the age of 17, U.S. Health and Human Services Secretary Kathleen Sebelius announced Wednesday.

The surprise move came the same day that the U.S. Food and Drug Administration was expected make the controversial drug available to all females without a prescription.

Sebelius said she was concerned that very young girls couldn't properly understand how to use the drug without assistance from an adult, according to news reports.

The decision means that teens 16 and younger can only buy Plan B, which costs about , with a prescription. Teens 17 and older, however, can continue to purchase the so-called morning-after pill without a prescription if they provide proof of age.

Plan B prevents pregnancy if taken within three days after having sex, according to the manufacturer, Israel-based Teva Pharmaceutical Industries Ltd.

Following Sebelius' announcement, FDA Commissioner Dr. Margaret Hamburg issued a statement that said her agency had found "there is adequate and reasonable, well-supported, and science-based evidence that Plan B One-Step is safe and effective and should be approved for nonprescription use for all females of child-bearing potential.

"However," she added, "this morning I received a memorandum from the Secretary of Health and Human Services invoking her authority under the Federal Food, Drug, and Cosmetic Act to execute its provisions and stating that she does not agree with the agency's decision to allow the marketing of Plan B One-Step nonprescription for all females of child-bearing potential. Because of her disagreement with FDA's determination, the secretary has directed me to issue a complete response letter, which means that the supplement for nonprescription use in females under the age of 17 is not approved."

Plan B prevents implantation of a fertilized egg in a woman's uterus through use of levonorgestrel, a synthetic hormone used for decades in birth control pills. Plan B contains 1.5 milligrams of levonorgestrel, more than "the Pill" contains.

The drug maker said that Plan B is safe for younger teens and that they should have it available to them as needed. The company submitted a study to the FDA that found girls 11 to 16 years old are capable of following the directions for usage, according to theWall Street Journal.

Watson Pharmaceuticals Inc., of Corona, Calif., makes a similar emergency contraceptive called Next Choice, which involves taking two levonorgestrel pills of lower dosage, either together or over a 24-hour period, according to the U.S. National Institutes of Health. Like Plan B, a customer's age determines whether Next Choice can be bought over the counter or by prescription.

Plan B was approved in 1999 as prescription-only. It wasn't until 2006 — after much heated debate — that the FDA eased the prescription requirement for older teens.

Plan B generated controversy in some quarters, including conservative political and religious groups. Wendy Wright, former president and CEO of Concerned Women for America, a political action group, cited safety issues associated with oral contraceptives and said young teens without medical supervision and parental awareness could face serious health risks.

Wright also argued that easing access would place a "huge burden" on pharmacists to provide patient counseling.

Safety issues concerning birth control pills have led the FDA to consider requiring new warning labels about increased risk of blood clots with newer forms of oral contraceptives. The concern centers around oral contraceptives such as Bayer's Yaz or Yasmin that contain a newer type of progestin hormone called drospirenone. A decision on the labeling may be made by Friday, the agency said this week.






Video: Alan Grayson calls appointment of Heather Nauert ‘pathetic’

U.S. Health Secretary Says No to Morning-After Pill for Younger Teens
U.S. Health Secretary Says No to Morning-After Pill for Younger Teens images

2019 year
2019 year - U.S. Health Secretary Says No to Morning-After Pill for Younger Teens pictures

U.S. Health Secretary Says No to Morning-After Pill for Younger Teens forecast
U.S. Health Secretary Says No to Morning-After Pill for Younger Teens forecast photo

U.S. Health Secretary Says No to Morning-After Pill for Younger Teens pics
U.S. Health Secretary Says No to Morning-After Pill for Younger Teens pics

U.S. Health Secretary Says No to Morning-After Pill for Younger Teens U.S. Health Secretary Says No to Morning-After Pill for Younger Teens new photo
U.S. Health Secretary Says No to Morning-After Pill for Younger Teens new pics

pics U.S. Health Secretary Says No to Morning-After Pill for Younger Teens
images U.S. Health Secretary Says No to Morning-After Pill for Younger Teens

Watch U.S. Health Secretary Says No to Morning-After Pill for Younger Teens video
Watch U.S. Health Secretary Says No to Morning-After Pill for Younger Teens video

Communication on this topic: U.S. Health Secretary Says No to Morning-After , u-s-health-secretary-says-no-to-morning-after/
Forum on this topic: U.S. Health Secretary Says No to Morning-After , u-s-health-secretary-says-no-to-morning-after/ , u-s-health-secretary-says-no-to-morning-after/

Related News


How to Plant Azaleas
Meghan Markle shares details of her ideal wedding dress
There Are 10 Types Of People Who Are More At Risk For Vitamin D Deficiency
9 of the Hottest Things Women Have Ever Said to Men
How to Be a Good Parent for Your Teenage Daughter
Reuben Wraps
4 Super-Important Foot Stretches for Runners
The Evolution Of Lingerie Over The Decades
Tetrahydrozoline Nasal
Exemestane Reviews



Date: 10.12.2018, 00:02 / Views: 42173